Inclusion criteria
cancer, carcinoma or carcinoma
ONCOLOGY, CANCER, DISEASE, NON-MUSCLE INVASIVE BLADDER CANCER

Men aged ≥ 18 with histologically confirmed low or intermediate risk PCa per NCCN guidelinesEastern Cooperative Oncology Group (ECOG) score of 0 – 1IPSS < 18Ability to receive MR-guided radiotherapyAbility to complete the EPIC questionnairePatients with a prior or concurrent disease whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial. Note: Any patient with a cancer (other than keratinocyte carcinoma or carcinoma in situ or low-grade non-muscle invasive bladder cancer) who has been disease-free for less than 3 years must contact the Principal Investigator.